Drug Research
NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy...
NexImmune, an emerging leader in the field of antigen-directed immunotherapy, announced the closing of a Series A financing co-led by new investor ArrowMark Partners and...
Drug Research
Idorsia forms research collaboration with Roche in the field...
Idorsia Ltd announced that it has entered into a research collaboration that provides Roche with an exclusive option right to develop and market first-in-class compounds...
Drug Research
NorthSea Therapeutics Secures €25 Million Funding for Clinical Development...
NorthSea Therapeutics B.V. , a newly established Dutch biotech company, announced the completion of a €25m Series A funding for the development of icosabutate, a...
Drug Research
Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for...
Agendia, a world leader in personalized medicine and molecular cancer diagnostics, and Institute Curie in Paris, France, a leading player in the fight against cancer....
Drug Research
Torque Launches Platform to Develop New Class of Deep...
Torque, an immuno-oncology company developing Deep Primed cell therapies that direct and evoke immune responses in the tumor microenvironment, announced the launch of its technology...
Drug Research
Eisai: Antiepileptic Drug Fycompa Regularly Available Again in Germany...
Eisai Co., Ltd. has announced that its German sales company Eisai GmbH and the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) have agreed on...
Drug Research
ANTABIO Raises € 7.3M Series A Financing to Develop...
Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today the completion of a €7.3M series. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.